The adipose tissue as a multifunctional organ;Il tessuto adiposo come organo multifunzionale

Giornale Italiano di Cardiologia

Volumn 9, Issue 4 SUPPL.1, 2008, Pages

  Bon, Gabriele Bittolo ^a  

^a Dipartimento di Medicina Clinica   (Italy)

Author keywords

Adipocyte; Adipokines; Adipose tissue; Central obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; GENETICS; HUMAN; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADIPOCYTES; ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; LEPTIN; METABOLIC SYNDROME X; OBESITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 54049111807     PISSN: 18276806     EISSN: 19726481     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Cinti S. The adipose organ. Milano: Kurtis, 1999.
2. Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007; 293: 444-52.
3. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145-58.
4. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60: 329-39.
5. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006; 55: 1537-45.
6. Jernas M, Palming J, Sjoholm K, et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006; 20: 1540-2.
7. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity- linked insulin resistance. Science 1993; 259: 87-91.
8. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30.
9. White RT, Damm D, Hancock N, et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 1992; 267: 9210-3.
10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
11. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-55.
12. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetic gene encodes the leptin receptor: identification of a mutation in the lebtin gene in db/db mice. Cell 1996; 84: 491-5.
13. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity. T cell hyporesponsiveness, and neuroendocrine/ metabolic dysfunction in human congenital leptin deficiency. J Clin Invest 2002; 110: 1093-103.
14. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Jnt J Obes Relat Metab Disord 2002; 26: 1407-33.
15. Mertens I, Considine RV, Van der Planken M, Van Gaal LF. Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin? Eur J Endocrinol 2006; 155: 477-84.
16. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab 2007; 9: 282-9.
17. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-92.
18. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-7.
19. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-30.
20. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-62.
21. Goossens GH, Blaak EE, van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev 2003, 4: 43-55.
22. Ferder l, Inserra F, Martinez-Maldonado M. Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress. Curr Hypertens Rep 2006; 8: 191-8.
23. Bujalska IJ, Kumar S, Hewison M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 1999; 140: 3188-96.
24. Sukhija R, Kakar P, Metha V, Metha JL. Enhanced 11betahydroxysteroid dehydrogenase activity, the metabolic syndrome, and systemic hypertension. Am J Cardiol 2006; 98: 544-8.
25. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-56.
26. Ma LJ, Mao SL, Taylor KL, et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 2004; 53: 336-46.
27. Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest 2006; 116: 33-5.
28. Yusuf F, Hawken S, Ounpuu S, et al, for the INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a casecontrol study. Lancet 2005; 366: 1640-9.
29. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-49.